The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
Open accessAbstract
Because of the role of thrombin and platelets in myocardial infarction and other pathological processes, identifying and blocking the receptors by which thrombin activates platelets has been an important goal. Three protease-activated receptors (PARs) for thrombin -- PAR1, PAR3, and PAR4 -- are now known. PAR1 functions in human platelets, and the recent observation that a PAR4-activating peptide activates human platelets suggests that PAR4 also acts in these cells. Whether PAR1 and PAR4 account for activation of human platelets by thrombin, or whether PAR3 or still other receptors contribute, is unknown. We have examined the roles of PAR1, PAR3, and PAR4 in platelets. PAR1 and PAR4 mRNA and protein were detected in human platelets. Activation of either receptor was sufficient to trigger platelet secretion and aggregation. Inhibition of PAR1 alone by antagonist, blocking antibody, or desensitization blocked platelet activation by 1 nM thrombin but only modestly attenuated platelet activation by 30 nM thrombin. Inhibition of PAR4 alone using a blocking antibody had little effect at either thrombin concentration. Strikingly, simultaneous inhibition of both PAR1 and PAR4 virtually ablated platelet secretion and aggregation, even at 30 nM thrombin. These observations suggest that PAR1 and PAR4 account for most, if not all, thrombin signaling in platelets and that antagonists that block these receptors might be useful antithrombotic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
Self-citationAspirin Selectively Inhibits Prostaglandin Production in Human Platelets
SMITH, J. B., & WILLIS, A. L. (1971) · Nature New Biology · doi:10.1038/newbio231235a0 · Cited by 1,521
A dual thrombin receptor system for platelet activation
Kahn, M. L., Zheng, Y.-W., Huang, W., Bigornia, V., Zeng, D., Moff, S., Farese, R. V., Tam, C., & Coughlin, S. R. (1998) · Nature · doi:10.1038/29325 · Cited by 979
Self-citationAspirin as an Antiplatelet Drug
Wood, A. J. J., & Patrono, C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301808 · Cited by 955
Protease-activated receptor 3 is a second thrombin receptor in humans
Ishihara, H., Connolly, A. J., Zeng, D., Kahn, M. L., Wu Zheng, Y., Timmons, C., Tram, T., & Coughlin, S. R. (1997) · Nature · doi:10.1038/386502a0 · Cited by 865
Self-citationCloning and characterization of human protease-activated receptor 4
Xu, W.-F., Andersen, H., Whitmore, T. E., Presnell, S. R., Yee, D. P., Ching, A., Gilbert, T., Davie, E. W., & Foster, D. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6642 · Cited by 817
Platelets in Biology and Pathology
Gordon, J. L. (1981) · Medical Entomology and Zoology · Cited by 638
Domains specifying thrombin–receptor interaction
Vu, T.-K. H., Wheaton, V. I., Hung, D. T., Charo, I., & Coughlin, S. R. (1991) · Nature · doi:10.1038/353674a0 · Cited by 552
Self-citationRole of the thrombin receptor in development and evidence for a second receptor
Connolly, A. J., Ishihara, H., Kahn, M. L., Farese, R. V., & Coughlin, S. R. (1996) · Nature · doi:10.1038/381516a0 · Cited by 505
Self-citationBalsano, F., Rizzon, P., Violi, F., Scrutinio, D., Cimminiello, C., Aguglia, F., Pasotti, C., & Rudelli, G. (1990) · Circulation · doi:10.1161/01.cir.82.1.17 · Cited by 386
Actions of Thrombin and Other Coagulant and Proteolytic Enzymes on Blood Platelets
DAVEY, M. G., & LÜSCHER, E. F. (1967) · Nature · doi:10.1038/216857a0 · Cited by 314
Vassallo, R. R., Kieber-Emmons, T., Cichowski, K., & Brass, L. F. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42664-6 · Cited by 299
Scarborough, R. M., Naughton, M. A., Teng, W., Hung, D. T., Rose, J., Vu, T. K., Wheaton, V. I., Turck, C. W., & Coughlin, S. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42184-9 · Cited by 286
Self-citationCharacterization of a new megakaryocytic cell line: the Dami cell
Greenberg, S., Rosenthal, D., Greeley, T., Tantravahi, R., & Handin, R. (1988) · Blood · doi:10.1182/blood.v72.6.1968.1968 · Cited by 284
Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling
Ishii, K., Hein, L., Kobilka, B., & Coughlin, S. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98415-2 · Cited by 205
Self-citationChen, J., Ishii, M., Wang, L., Ishii, K., & Coughlin, S. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33970-4 · Cited by 194
Self-citationBrass, L. F., Vassallo, R. R., Belmonte, E., Ahuja, M., Cichowski, K., & Hoxie, J. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49635-x · Cited by 185
Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation.
Hung, D. T., Vu, T. K., Wheaton, V. I., Ishii, K., & Coughlin, S. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115721 · Cited by 183
Self-citationTerritoriality in the White Rhinoceros (Ceratotherium simum) Burchell
OWEN-SMITH, N. (1971) · Nature · doi:10.1038/231294a0 · Cited by 166
Antiplatelet treatment with ticlopidine in unstable angina: A controlled multicenter clinical trial
BALSANO, F., RIZZON, P., Violi, F., et al. (1990) · Circulation · Cited by 161
Proteinase-activated receptor-2: expression by human neutrophils
Howells, G. L., Macey, M. G., Chinni, C., Hou, L., Fox, M. T., Harriott, P., & Stone, S. R. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.7.881 · Cited by 158
Secondary and Tertiary Structure Changes of Reconstituted P-glycoprotein
Sonveaux, N., Shapiro, A. B., Goormaghtigh, E., Ling, V. W. T., & Ruysschaert, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24617 · Cited by 151
Development of Potent Thrombin Receptor Antagonist Peptides
Bernatowicz, M. S., Klimas, C. E., Hartl, K. S., Peluso, M., Allegretto, N. J., & Seiler, S. M. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960455s · Cited by 144
Role of the Thrombin Receptor's Cytoplasmic Tail in Intracellular Trafficking
Shapiro, M. J., Trejo, J., Zeng, D., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32874 · Cited by 139
Self-citationTrejo, J., Connolly, A. J., & Coughlin, S. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21536 · Cited by 128
Self-citationThe Human Proteinase-activated Receptor-3 (PAR-3) Gene
Schmidt, V. A., Nierman, W. C., Maglott, D. R., Cupit, L. D., Moskowitz, K. A., Wainer, J. A., & Bahou, W. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15061 · Cited by 117
Antibodies to Protease-Activated Receptor 3 Inhibit Activation of Mouse Platelets by Thrombin
Ishihara, H., Zeng, D., Connolly, A. J., et al. (1998) · Blood · doi:10.1182/blood.v91.11.4152 · Cited by 74
Self-citationDerian, C. K., Santulli, R. J., Tomko, K. A., et al. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)00084-5 · Cited by 72
Ishii, K., Gerszten, R. E., Zheng, Y. W., Welsh, J. B., Turck, C. W., & Coughlin, S. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16435 · Cited by 64
Self-citation
Cited by
Thrombin signalling and protease-activated receptors
Coughlin, S. R. (2000) · Nature · doi:10.1038/35025229 · Cited by 2,482
Self-citationProteinase-activated Receptors
(2006) · Encyclopedic Reference of Molecular Pharmacology · doi:10.1007/3-540-29832-0_1335 · Cited by 1,137
Protease-Activated Receptors: Contribution to Physiology and Disease
OSSOVSKAYA, V. S., & BUNNETT, N. W. (2004) · Physiological Reviews · doi:10.1152/physrev.00028.2003 · Cited by 1,078
Protease‐activated receptors in hemostasis, thrombosis and vascular biology
COUGHLIN, S. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01377.x · Cited by 1,035
Self-citationTobacco smoking leads to extensive genome-wide changes in DNA methylation
Zeilinger, S., Kühnel, B., Klopp, N., Baurecht, H., Kleinschmidt, A., Gieger, C., Weidinger, S., Lattka, E., Adamski, J., Peters, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063812 · Cited by 824
“The F2RL3 protein is relevant for cardiovascular physiology and plays a role in platelet activation [40] and cell signaling [4].”
Background
Metadata
- Authors
- Kahn, M. L., Nakanishi-Matsui, M., Shapiro, M. J., Ishihara, H., & Coughlin, S. R.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-03-15
- Volume
- 103
- Issue
- 6
- Pages
- 879-887
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2091112630
- Cited by
- 841
- References
- 29
- FWCI
- 19.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.